- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Type-2-diabetes Mellitus in South Africa
Total 1011 results
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesSouth Africa, Germany, Hungary, Romania, Slovakia, Switzerland, Ukraine
-
Response PharmaceuticalsCompletedType 2 Diabetes MellitusUnited States
-
SanofiHanmi Pharmaceutical Company LimitedTerminatedType 2 Diabetes MellitusEstonia, Spain, Ukraine, Italy, Germany, Canada, Mexico, United States, Argentina, Bulgaria, Chile, Denmark, Finland, Hungary, India, Korea, Republic of, Latvia, Lithuania, Norway, Peru, Poland, Romania, Russian Federation, Serbia, Slov... and more
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesMorocco, Tunisia, Algeria, South Africa, Egypt
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2United States, France, Switzerland, Germany, South Africa, Korea, Republic of, Puerto Rico, Canada, Taiwan, Spain, Poland, Slovakia, Thailand, Mexico, Turkey, Australia, Greece, Norway, Sweden, Peru, Romania, Argentina, United Kingdom
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Spain, Canada
-
AstraZenecaEli Lilly and CompanyCompleted
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2France, Poland, United Kingdom, United States, Spain, Colombia, India, Romania, South Africa, Ukraine, Australia, Canada, Greece, Sweden, New Zealand, Switzerland, Hong Kong
-
Bristol-Myers SquibbMerck Sharp & Dohme LLCCompletedType 2 Diabetes MellitusUnited States, Argentina, Canada, Mexico, Peru, Taiwan, Australia, Philippines, Thailand, Brazil, Chile, India, Russian Federation, Ukraine
-
Gilead SciencesCompletedType 2 Diabetes MellitusUnited States, Russian Federation, Thailand, Serbia, Poland, Hungary, Malaysia, South Africa, Ukraine, Czech Republic, Romania, Slovakia
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2United States, Estonia, Latvia, Mexico
-
MedImmune LLCCompleted
-
AstraZenecaCompletedType 2 Diabetes MellitusBrazil, Italy, Korea, Republic of, Mexico, Poland, Russian Federation, South Africa, Spain, Turkey, China, Netherlands, Argentina, Austria, Czechia, United Arab Emirates, Taiwan, India, Egypt, Saudi Arabia, Lebanon, Indonesia, Col... and more
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusRussian Federation, United States, Puerto Rico, Australia, Taiwan, Israel, Spain, Canada, Greece, Argentina, Poland, Romania, Mexico, Slovakia, Brazil
-
University of LiverpoolAstraZeneca; Clinical Practice Research DatalinkActive, not recruitingType 2 Diabetes MellitusUnited Kingdom
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Canada, Romania, Russian Federation, Ukraine, Germany, Spain, Philippines, Czech Republic, Mexico, Croatia, Chile, Morocco, South Africa, Australia, Venezuela
-
TakedaCompletedType 2 Diabetes MellitusUnited States, Australia, Brazil, Bulgaria, Chile, Croatia, Estonia, Guatemala, India, Israel, Latvia, Mexico, New Zealand, Peru, Romania, Russian Federation, Serbia, South Africa, Ukraine
-
Eli Lilly and CompanyAlkermes, Inc.CompletedDiabetes Mellitus, Type 2United States, Argentina, Portugal, South Africa
-
Novo Nordisk A/SRecruitingDiabetes, Type 2United States, India, Spain, Poland, South Africa, Bulgaria, Germany, Japan, Puerto Rico
-
Lexicon PharmaceuticalsCompletedType 2 Diabetes MellitusUnited States
-
Novo Nordisk A/SRecruitingType 2 Diabetes MellitusKorea, Republic of, United States, Serbia, Hungary, Spain, China, Australia, Finland, United Kingdom, Italy, Denmark, Canada, Taiwan, Germany, Sweden, South Africa, India, Poland, Argentina, Brazil, Bulgaria, Japan, Mexico, Turkey, Greece, Colomb... and more
-
AstraZenecaQuintiles, Inc.CompletedType 2 DiabetesUnited States, Korea, Republic of, India, Russian Federation, Brazil, Mexico, South Africa, Philippines
-
InteKrin Therapeutics, Inc.CompletedType 2 Diabetes MellitusUnited States, Mexico
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Mexico, India
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesUnited States, Peru, Mexico, Colombia, Costa Rica
-
SanofiCompletedType 2 Diabetes MellitusEstonia, Italy, Israel, United States, Canada, Germany, Romania, Slovakia, Spain
-
Concert PharmaceuticalsCompletedType 2 Diabetes Mellitus | Chronic Kidney DiseaseUnited States
-
TakedaTerminatedType 2 Diabetes MellitusUnited States, Poland, Ukraine, Taiwan, Bulgaria, Romania, Slovakia
-
AstraZenecaTerminatedType 2 Diabetes MellitusUnited States
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesSweden, France, Italy, Mexico, South Africa, Spain, Germany, Netherlands, Argentina, United Kingdom
-
Response PharmaceuticalsCompletedType 2 DiabetesUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerTerminatedDiabetes MellitusChina, United States, Canada, Mexico, Russian Federation, Croatia, United Kingdom, Argentina, Australia, India, South Africa, Greece, Ukraine, Romania, Italy, Hong Kong, Former Serbia and Montenegro, Brazil
-
Yaounde Central HospitalUniversity of Exeter; University of Yaounde 1; MRC/UVRI & LSHTM Uganda Research...RecruitingType 1 Diabetes | Diabetes, AutoimmuneTanzania, Cameroon, South Africa, Uganda
-
Konstantinos Makrilakis, MDUni-PharmaEnrolling by invitationDiabetes Mellitus, Type 2Greece
-
Harokopio UniversityCompletedDiabetes Mellitus, Type 2Greece
-
Gilead SciencesCompletedType 2 Diabetes MellitusUnited States, Russian Federation, Serbia, Poland, Hungary, South Africa, Ukraine, Romania, Slovakia, Czech Republic
-
AstraZenecaCompletedType 2 DiabetesUnited States
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Korea, Republic of, Taiwan, Italy, Austria, Puerto Rico, Hungary, Greece, Poland, Spain, Romania, Ukraine, Argentina
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Bulgaria, Canada, Czech Republic, Denmark, Estonia, Finland, Hungary, Japan, Latvia, Lithuania, Netherlands, Puerto Rico, Romania, Slovakia, Sweden
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Hungary, Puerto Rico, Spain, Australia, Korea, Republic of, Mexico, Japan, Germany, Russian Federation, Taiwan, Slovakia, Argentina, Czechia, India, Italy
-
Zafgen, Inc.TerminatedObesity | Type 2 DiabetesAustralia
-
Daiichi Sankyo, Inc.TerminatedType 2 Diabetes MellitusUnited States
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Australia, Spain, Korea, Republic of, Hungary, Mexico, Italy, Poland, Argentina, Canada, Colombia, France, Germany, Japan, Peru, Romania, Sweden, United Kingdom
-
AstraZenecaCompletedType 2 Diabetes MellitusKorea, Republic of
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, South Africa, Canada
-
AstraZenecaBristol-Myers SquibbCompletedStudy of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 DiabetesType 2 Diabetes MellitusKorea, Republic of, United States, Mexico, India, Puerto Rico, Russian Federation
-
TakedaCompletedDiabetes MellitusUnited States, Australia, Brazil, Guatemala, India, Mexico, New Zealand, Peru, South Africa, Czech Republic, Germany, Hungary, Netherlands, Argentina
-
AstraZenecaTerminatedType 2 DiabetesItaly, Poland, South Africa, Norway, Belgium, Hungary, Slovakia, Taiwan, Philippines, Thailand, Mexico, Hong Kong, Malaysia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Bahrain, Egypt, Jordan, Kuwait, Qatar, South Africa, United Arab Emirates